I hope/wish/ believe that Celgro nerve has the
potential to be a blockbuster but, ATI and Celgro
bone/dental will just tag along behind as minor
contributors.
There just seems to be so little enthusiasm for ATI
in this country, despite the availablity of the
procedure for so long. Don’t see how regulatory
approval will change the situation that much.
Further CelGro® nerve clinical trial data from all patients at 12 months, page-61
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
-0.020(2.92%) |
Mkt cap ! $159.0M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.0¢ | $245.7K | 371.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 12621 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |